ANI Pharmaceuticals Inc. (ANIP) Hits New 52-week Low During January 28 Session

Equities Staff |

ANI Pharmaceuticals Inc. (ANIP) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $33.07, ANI Pharmaceuticals Inc. dropped to $30.93 for a new 52-week low. By the closing bell, the company's stock was at $31.51 a share for a loss of 3.58%.

Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

However one plays it, it's often a critical moment for any stock and should be noted by investors.

ANI Pharmaceuticals Inc. saw 186,093 shares of its stock trade hands, that's out of 11.5 million shares outstand. The stock has an average daily volume of 368,124 shares. After hitting a new 52-week low, ANI Pharmaceuticals Inc. enters the new trading day with a market cap of 362.37 million, a 50-day SMA of $41.83 and a 200-day SMA of $51.24

ANI Pharmaceuticals Inc. now has a P/E ratio of 11.7.

For a complete fundamental analysis analysis of ANI Pharmaceuticals Inc., check out’s Stock Valuation Analysis report for ANIP. To see the latest independent stock recommendations from’s analysts, visit our Research section.

ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary develops, manufactures and markets branded and generic prescription pharmaceuticals products.

ANI Pharmaceuticals Inc. has 92 employees, is led by CEO Arthur S. Przybyl, and makes its home in Baudette, MN.

ANI Pharmaceuticals Inc. is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.

The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…